Studies

  1. Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease

  2. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry

  3. Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer’s global safety database

  4. Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis

  5. Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis

  6. Maternal and Neonatal Outcomes in Vedolizumab and Ustekinumab Exposed Pregnancies: Results from the PIANO registry

  7. Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis

  8. European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

  9. Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network

  10. Safety of vedolizumab and ustekinumab compared with anti-TNF in pregnant women with inflammatory bowel disease